Triple negative breast cancer (TNBC) are tumors that lack expression of estrogen receptor α (ERα), progesterone receptor (PR), and amplification/overexpression of human epidermal growth factor receptor 2 (HER2/neu). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.